Table of Content



1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
1.2 Key Market Segments
1.2.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Type
1.2.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats

2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Competitive Landscape
3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturers (2017-2022)
3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Manufacturers (2017-2022)
3.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Sites, Area Served, Product Type
3.6 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Competitive Situation and Trends
3.6.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion

4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Chain Analysis
4.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 The Development and Dynamics of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2017-2022)
6.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Market Share by Type (2017-2022)
6.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2017-2022)

7 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Sales by Application (2017-2022)
7.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (M USD) by Application (2017-2022)
7.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate by Application (2017-2022)

8 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segmentation by Region
8.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region
8.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region
8.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa

9 Key Companies Profiled
9.1 Heron Therapeutics
9.1.1 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.1.2 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.1.4 Heron Therapeutics Business Overview
9.1.5 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis
9.1.6 Heron Therapeutics Recent Developments
9.2 Merck
9.2.1 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.2.2 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Eisai
9.3.1 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.3.2 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.3.4 Eisai Business Overview
9.3.5 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis
9.3.6 Eisai Recent Developments
9.4 Mundipharma
9.4.1 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.4.2 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.4.4 Mundipharma Business Overview
9.4.5 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis
9.4.6 Mundipharma Recent Developments
9.5 Qilu Pharma
9.5.1 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.5.2 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.5.4 Qilu Pharma Business Overview
9.5.5 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis
9.5.6 Qilu Pharma Recent Developments
9.6 Teva
9.6.1 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.6.2 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.6.4 Teva Business Overview
9.6.5 Teva Recent Developments
9.7 Novartis
9.7.1 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.7.2 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 Roche
9.8.1 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.8.2 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.8.4 Roche Business Overview
9.8.5 Roche Recent Developments
9.9 Mylan
9.9.1 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.9.2 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.9.4 Mylan Business Overview
9.9.5 Mylan Recent Developments
9.10 Baxter
9.10.1 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.10.2 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.10.4 Baxter Business Overview
9.10.5 Baxter Recent Developments
9.11 GSK
9.11.1 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.11.2 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.11.4 GSK Business Overview
9.11.5 GSK Recent Developments
9.12 Helsinn
9.12.1 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.12.2 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.12.4 Helsinn Business Overview
9.12.5 Helsinn Recent Developments
9.13 Southwest Pharma
9.13.1 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.13.2 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.13.4 Southwest Pharma Business Overview
9.13.5 Southwest Pharma Recent Developments
9.14 Haisco
9.14.1 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.14.2 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.14.4 Haisco Business Overview
9.14.5 Haisco Recent Developments
9.15 Sun Pharma
9.15.1 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information
9.15.2 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview
9.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance
9.15.4 Sun Pharma Business Overview
9.15.5 Sun Pharma Recent Developments

10 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Region
10.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast
10.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Region
10.2.4 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Country

11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type (2022-2028)
11.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type (2022-2028)
11.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Application (2022-2028)
11.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units) Forecast by Application
11.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (M USD) Forecast by Application (2022-2028)

12 Conclusion and Key Findings



List of Figures

Table of Contents
1 Research Methodology and Statistical Scope 1
1.1 Market Definition and Statistical Scope of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs 1
1.2 Key Market Segments 1
1.2.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Type 1
1.2.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Application 2
1.3 Methodology & Sources of Information 3
1.3.1 Research Methodology 3
1.3.2 Research Process 4
1.3.3 Market Breakdown and Data Triangulation 5
1.3.4 Base Year 5
1.3.5 Report Assumptions & Caveats 6
2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Overview 8
2.1 Global Market Overview 8
2.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (M USD) Estimates and Forecasts (2017-2028) 8
2.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Estimates and Forecasts (2017-2028) 9
2.2 Market Segment Executive Summary 9
2.3 Global Market Size by Region 11
3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Competitive Landscape 13
3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturers (2017-2022) 13
3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Manufacturers (2017-2022) 15
3.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 16
3.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Manufacturers (2017-2022) 17
3.5 Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Sites, Area Served, Product Type 18
3.6 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Competitive Situation and Trends 19
3.6.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Concentration Rate 19
3.6.2 Global 5 and 10 Largest Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue 21
3.6.3 Mergers & Acquisitions, Expansion 21
4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Chain Analysis 22
4.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Chain Analysis 22
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 22
4.3 Midstream Market Analysis 23
4.4 Downstream Customer Analysis 23
5 The Development and Dynamics of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market 25
5.1 Key Development Trends 25
5.2 Driving Factors 25
5.3 Market Challenges 25
5.4 Market Restraints 26
5.5 Industry News 26
5.5.1 New Product Developments 26
5.5.2 Mergers & Acquisitions 26
5.5.3 Expansions 26
5.5.4 Collaboration/Supply Contracts 26
5.6 Industry Policies 26
6 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segmentation by Type 27
6.1 Evaluation Matrix of Segment Market Development Potential (Type) 27
6.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2017-2022) 28
6.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Market Share by Type (2017-2022) 29
6.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2017-2022) 30
7 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segmentation by Application 31
7.1 Evaluation Matrix of Segment Market Development Potential (Application) 31
7.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Sales by Application (2017-2022) 32
7.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (M USD) by Application (2017-2022) 33
7.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate by Application (2017-2022) 34
8 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segmentation by Region 35
8.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region 35
8.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region 35
8.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region 35
8.2 North America 36
8.2.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country 36
8.2.2 U.S. 37
8.2.3 Canada 37
8.2.4 Mexico 37
8.3 Europe 37
8.3.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country 38
8.3.2 Germany 38
8.3.3 France 38
8.3.4 U.K. 38
8.3.5 Italy 39
8.3.6 Russia 39
8.4 Asia Pacific 39
8.4.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region 39
8.4.2 China 40
8.4.3 Japan 40
8.4.4 South Korea 40
8.4.5 India 40
8.4.6 Southeast Asia 40
8.5 South America 40
8.5.1 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country 41
8.5.2 Brazil 41
8.5.3 Argentina 41
8.5.4 Columbia 41
8.6 Middle East and Africa 41
8.6.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region 42
8.6.2 Saudi Arabia 42
8.6.3 UAE 42
8.6.4 Egypt 42
8.6.5 Nigeria 43
8.6.6 South Africa 43
9 Key Companies Profiled 44
9.1 Heron Therapeutics 44
9.1.1 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 44
9.1.2 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 44
9.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 44
9.1.4 Heron Therapeutics Business Overview 45
9.1.5 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis 45
9.1.6 Heron Therapeutics Recent Developments 45
9.2 Merck 46
9.2.1 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 46
9.2.2 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 46
9.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 46
9.2.4 Merck Business Overview 47
9.2.5 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis 47
9.2.6 Merck Recent Developments 47
9.3 Eisai 47
9.3.1 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 47
9.3.2 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 48
9.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 48
9.3.4 Eisai Business Overview 48
9.3.5 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis 49
9.3.6 Eisai Recent Developments 49
9.4 Mundipharma 49
9.4.1 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 49
9.4.2 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 50
9.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 50
9.4.4 Mundipharma Business Overview 50
9.4.5 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis 50
9.4.6 Mundipharma Recent Developments 51
9.5 Qilu Pharma 51
9.5.1 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 51
9.5.2 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 51
9.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 52
9.5.4 Qilu Pharma Business Overview 52
9.5.5 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis 52
9.5.6 Qilu Pharma Recent Developments 52
9.6 Teva 53
9.6.1 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 53
9.6.2 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 53
9.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 53
9.6.4 Teva Business Overview 54
9.6.5 Teva Recent Developments 54
9.7 Novartis 54
9.7.1 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 54
9.7.2 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 55
9.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 55
9.7.4 Novartis Business Overview 55
9.7.5 Novartis Recent Developments 55
9.8 Roche 56
9.8.1 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 56
9.8.2 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 56
9.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 56
9.8.4 Roche Business Overview 57
9.8.5 Roche Recent Developments 57
9.9 Mylan 57
9.9.1 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 57
9.9.2 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 58
9.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 58
9.9.4 Mylan Business Overview 58
9.9.5 Mylan Recent Developments 58
9.10 Baxter 59
9.10.1 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 59
9.10.2 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 59
9.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 59
9.10.4 Baxter Business Overview 60
9.10.5 Baxter Recent Developments 60
9.11 GSK 60
9.11.1 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 60
9.11.2 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 61
9.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 61
9.11.4 GSK Business Overview 61
9.11.5 GSK Recent Developments 61
9.12 Helsinn 62
9.12.1 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 62
9.12.2 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 62
9.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 62
9.12.4 Helsinn Business Overview 63
9.12.5 Helsinn Recent Developments 63
9.13 Southwest Pharma 63
9.13.1 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 63
9.13.2 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 64
9.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 64
9.13.4 Southwest Pharma Business Overview 64
9.13.5 Southwest Pharma Recent Developments 64
9.14 Haisco 65
9.14.1 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 65
9.14.2 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 65
9.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 65
9.14.4 Haisco Business Overview 66
9.14.5 Haisco Recent Developments 66
9.15 Sun Pharma 66
9.15.1 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 66
9.15.2 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 67
9.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Market Performance 67
9.15.4 Sun Pharma Business Overview 67
9.15.5 Sun Pharma Recent Developments 67
10 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Region 106
10.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast 106
10.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Region 106
10.2.1 North America Market Size Forecast by Country 107
10.2.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country 108
10.2.3 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Region 108
10.2.4 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country 109
10.2.5 Middle East and Africa Forecasted Consumption of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Country 109
11 Forecast Market by Type and by Application (2022-2028) 111
11.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Type (2022-2028) 111
11.1.1 Global Forecasted Sales of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type (2022-2028) 111
11.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Type (2022-2028) 111
11.1.3 Global Forecasted Price of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type (2022-2028) 112
11.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Forecast by Application (2022-2028) 112
11.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units) Forecast by Application 112
11.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (M USD) Forecast by Application (2022-2028) 113
12 Conclusion and Key Findings 114

?
List of Tables
Table 1. Introduction of the Type 1
Table 2. Introduction of the Application 2
Table 3. Market Size (M USD) Segment Executive Summary 10
Table 4. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (M USD) Comparison by Region (M USD) 11
Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units) by Manufacturers (2017-2022) 13
Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturers (2017-2022) 14
Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (M USD) by Manufacturers (2017-2022) 15
Table 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers (2017-2022) 15
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs as of 2021) 16
Table 10. Global Market Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022) 17
Table 11. Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Sites and Area Served 18
Table 12. Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Type 18
Table 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) 20
Table 14. Mergers & Acquisitions, Expansion Plans 21
Table 15. Industry Chain Map of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs 22
Table 16. Raw Materials 22
Table 17. Midstream Market Analysis 23
Table 18. Downstream Customer Analysis 23
Table 19. Key Development Trends 25
Table 20. Driving Factors 25
Table 21. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Challenges 25
Table 22. Market Restraints 26
Table 23. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (K Units) 27
Table 24. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type (M USD) 28
Table 25. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units) by Type (2017-2022) 28
Table 26. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2017-2022) 28
Table 27. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (M USD) by Type (2017-2022) 29
Table 28. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Share by Type (2017-2022) 29
Table 29. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (USD/Unit) by Type (2017-2022) 30
Table 30. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units) by Application 31
Table 31. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application 32
Table 32. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2017-2022) & (K Units) 32
Table 33. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2017-2022) 32
Table 34. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2017-2022) & (M USD) 33
Table 35. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Application (2017-2022) 33
Table 36. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate by Application (2017-2022) 34
Table 37. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2017-2022) & (K Units) 35
Table 38. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2017-2022) 35
Table 39. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2017-2022) & (K Units) 36
Table 40. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2017-2022) & (K Units) 38
Table 41. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2017-2022) & (K Units) 39
Table 42. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2017-2022) & (K Units) 41
Table 43. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2017-2022) & (K Units) 42
Table 44. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 44
Table 45. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 44
Table 46. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 44
Table 47. Heron Therapeutics Business Overview 45
Table 48. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis 45
Table 49. Heron Therapeutics Recent Developments 45
Table 50. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 46
Table 51. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 46
Table 52. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 46
Table 53. Merck Business Overview 47
Table 54. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis 47
Table 55. Merck Recent Developments 47
Table 56. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 47
Table 57. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 48
Table 58. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 48
Table 59. Eisai Business Overview 48
Table 60. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis 49
Table 61. Eisai Recent Developments 49
Table 62. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 49
Table 63. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 50
Table 64. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 50
Table 65. Mundipharma Business Overview 50
Table 66. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis 50
Table 67. Mundipharma Recent Developments 51
Table 68. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 51
Table 69. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 51
Table 70. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 52
Table 71. Qilu Pharma Business Overview 52
Table 72. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs SWOT Analysis 52
Table 73. Qilu Pharma Recent Developments 52
Table 74. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 53
Table 75. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 53
Table 76. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 53
Table 77. Teva Business Overview 54
Table 78. Teva Recent Developments 54
Table 79. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 54
Table 80. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 55
Table 81. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 55
Table 82. Novartis Business Overview 55
Table 83. Novartis Recent Developments 55
Table 84. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 56
Table 85. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 56
Table 86. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 56
Table 87. Roche Business Overview 57
Table 88. Roche Recent Developments 57
Table 89. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 57
Table 90. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 58
Table 91. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 58
Table 92. Mylan Business Overview 58
Table 93. Mylan Recent Developments 58
Table 94. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 59
Table 95. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 59
Table 96. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 59
Table 97. Baxter Business Overview 60
Table 98. Baxter Recent Developments 60
Table 99. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 60
Table 100. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 61
Table 101. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 61
Table 102. GSK Business Overview 61
Table 103. GSK Recent Developments 61
Table 104. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 62
Table 105. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 62
Table 106. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 62
Table 107. Helsinn Business Overview 63
Table 108. Helsinn Recent Developments 63
Table 109. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 63
Table 110. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 64
Table 111. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 64
Table 112. Southwest Pharma Business Overview 64
Table 113. Southwest Pharma Recent Developments 64
Table 114. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 65
Table 115. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 65
Table 116. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 65
Table 117. Haisco Business Overview 66
Table 118. Haisco Recent Developments 66
Table 119. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Basic Information 66
Table 120. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Overview 67
Table 121. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 67
Table 122. Sun Pharma Business Overview 67
Table 123. Sun Pharma Recent Developments 67
Table 124. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Region (K Units) 106
Table 125. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Region (M USD) 107
Table 126. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2022-2028) & (K Units) 107
Table 127. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2022-2028) & (M USD) 107
Table 128. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2022-2028) & (K Units) 108
Table 129. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2022-2028) & (M USD) 108
Table 130. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Region (2022-2028) & (K Units) 108
Table 131. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Region (2022-2028) & (M USD) 109
Table 132. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Country (2022-2028) & (K Units) 109
Table 133. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2022-2028) & (M USD) 109
Table 134. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Forecast by Country (2022-2028) & (Units) 109
Table 135. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Country (2022-2028) & (M USD) 110
Table 136. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2022-2028) & (K Units) 111
Table 137. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Type (2022-2028) & (M USD) 111
Table 138. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Forecast by Type (2022-2028) & (USD/Unit) 112
Table 139. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (K Units) Forecast by Application (2022-2028) 112
Table 140. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Application (2022-2028) & (M USD) 113